| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Werewolf Therapeutics, Inc.
13G
HOWL · 95075A107
|
5.2% |
9/21/2026
Event 9/18/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.